Immunosenescence and vaccine failure in the elderly

Aging Clinical and Experimental Research

Volumn 21, Issue 3, 2009, Pages 201-209

  Grubeck Loebenstein, Beatrix ^a   Della Bella, Silvia ^b   Iorio, Anna Maria ^c   Michel, Jean Pierre ^d   Pawelec, Graham ^e   Solana, Rafael ^f  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Adaptive immunity; Frailty; Immunosenescence; Innate immunity; Vaccination

Indexed keywords

CYTOKINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; VARICELLA ZOSTER VACCINE;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL SURVIVAL; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DENDRITIC CELL; DIPHTHERIA; DRUG EFFICACY; DRUG MEGADOSE; EFFECTOR CELL; ELDERLY CARE; FRAIL ELDERLY; HEALTH CARE PERSONNEL; HERPES ZOSTER; HUMAN; INFLUENZA; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; PERTUSSIS; PHAGOCYTOSIS; REVIEW; SENESCENCE; SEROCONVERSION; STREPTOCOCCUS PNEUMONIA; T LYMPHOCYTE; TETANUS; VACCINE FAILURE;

CYTOMEGALOVIRUS;

EID: 67651151156     PISSN: 15940667     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03324904     Document Type: Review

References (85)

1. Lutz W, Sanderson W, Scherbov S. Doubling of world population unlikely. Nature 1997; 387: 803-805
2. Weinberger B, Hemdler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B. Biology of immune responses to vaccines in the elderly. Clin Infect Dis 2008; 46: 1078-1084
3. Solana R, Pawelec G, Tarazona R. Aging and innate immunity. Immunity 2006; 24: 491-494
4. Di Santo JP. Natural killer cells: diversity in search of a niche. Nat Immunol 2008; 9: 473-475
5. Kutza J, Murasako DM. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha. Cell Immunol 1994; 155: 195-204.
6. Kutza J. Murasko DM. Age-associated decline in IL-2 and IL-12 induction of LAK cell activity of human PBMC samples. Mech Ageing Dev 1996; 90: 209-222
7. Solana R, Mariani E. NK and NK/T cells in human senescence. Vaccine 2000; 18: 1613-1620
8. Ogata K, An E, Shioi Y et al. Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol 2001; 124: 392-397
9. De la Rosa O, Pawelec G, Peralbo E et al. Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology 2006; 7: 471-481
10. Ogata K, Yokose N, Tamura H et al. Natural killer cells in the late decades of human life. Clin Immunol Immunopathol 1997; 84: 269-275
11. Remarque E, Pawelec G. T cell immunosenescence and its clinical relevance in man. Rev Clin Gerontol 1998; 8: 5-14.
12. Mysliwska J, Trzonkowski P, Szmit E, Brydak LB, Machala M, Mysliwski A. Immunomodulating effect of influenza vaccination in the elderly differing in health status. Exp Gerontol 2004; 39: 1447-1458
13. Sansoni P, Cossarizza A, Brianti V et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 1993; 82: 2767-2773
14. Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 1995; 16: 12-16
15. Shortman K, Naik SH, Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007; 7: 19-30.
16. Ueno H, Klechevsky E, Morita R et al. Dendritic cell subsets in health and disease. Immunol Rev 2007; 219: 118-142
17. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23: 275-306.
18. Della Bella S, Bierti L, Presicce P et al. Peripheral blood dendritic cells and monocytes are differentially regulated in the elderly. Clin Immunol 2007; 122: 220-228
19. Varas A, Sacédon R, Hernandez-López C et al. Age-dependent changes in thymic macrophages and dendritic cells. Microsc Res Tech 2003; 62: 501-507
20. Bhushan M, Cumberbatch M, Dearman RJ, Andrew SM, Kimber I, Griffiths CE. Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol 2002; 146: 32-40.
21. Tarazona R, Gayoso I, Alonso C et al. NK cells in human ageing. In Fülöp T, Hirokawa H, Pawelec G, Franceschi C, eds. Ageing, Immunity and Inflammation. Berlin: Springer Science 2009 (in press).
22. Franceschi C, Bonafè M, Valensin S et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000; 908: 244-254
23. Steinmann GG, Klaus B, Müller-Hermelink HK. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol 1985; 22: 563-575
24. Lazuardi L, Jenewein B, Wolf AM, Pfister G, Tzankov A, Grubeck-Loebenstein B. Age-related loss of naïve T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology 2005; 114: 37-43.
25. Pfister G, Weiskopf D, Lazuardi L et al. Naïve T cells in the elderly. Are they still there? Ann NY Acad Sci 2006; 1067: 152-157
26. Saurwein-Teissl M, Lung TL, Marx F et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002; 168: 5893-5899
27. Schwaiger S, Wolf A-M, Robatscher P, Jenewein B, Grubeck-Loebenstein B. IL-4 producing CD8+ T cells with a CD62L++(bright) phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age. J Immunol 2003; 170: 613-619
28. Hemdler-Brandstetter D, Schwaiger S, Veel E et al. CD25-expressing CD8+ T cells are potent memory cells in old age. J Immunol 2005; 175: 1566-1574
29. Lugli E, Pinti M, Nasi M et al. Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric data. Cytometry A 2007; 71: 334-344
30. Weng N. Aging of the immune system: how much can the adaptive immune system adapt? Immunity 2006; 24: 495-499
31. Almanzar G, Schwaiger S, Jenewein B et al. Long term CMV infection leads to significant changes in the composition of the CD8+ T cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 2005; 79: 3675-3683
32. Khan N, Shariff N, Cobbold M et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169: 1984-1992
33. Ouyang Q, Wagner WM, Voehringer D et al. Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp Gerontol 2003; 38: 911-920
34. Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO, Ferguson FG. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000; 121: 187-201.
35. Pawelec G, Ferguson FG, Wikby A. The SENIEUR protocol after 16 years. Mech Ageing Dev 2001; 122: 132-134
36. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, Ferguson F. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 2002; 37: 445-453
37. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev 1998; 102: 187-198
38. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci 1995; 50: B378-82.
39. Hadrup SR, Strindhall J, Kollgaard T et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional CMV specific T cells in the very elderly. J Immunol 2006; 176: 2645-2653
40. Wikby A, Nilsson BO, Forsey R et al. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late functioning. Mech Ageing Dev 2006; 127: 695-704.
41. Swain S, Clise-Dwyer K, Haynes L. Homeostasis and the age-associated defect of CD4 T cells. Semin Immunol 2005; 17: 370-377
42. Kovaiou RD, Weiskirchner I, Keller M, Pfister G, Cioca DP, Grubeck-Loebenstein B. Age-related differences in phenotype and function of CD4+ T cells are due to a phenoytypic shift from naïve to memory effector CD4+ T cells. Int Immunol 2005; 17: 1359-1366
43. Kang I, Hong MS, Nolasco H et al. Age-associated change in the frequency of memory CD4+ T cells impair long term CD4+ T cell responses to influenza vaccine. J Immunol 2004; 173: 673-681
44. Koch S, Larbi A, Derhovanessian E, Ozcelik D, Naumova E, Pawelec G. Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing 2008; 5: 6.
45. Allman D, Miller JP. B cell development and receptor diversity during aging. Curr Opin Immunol 2005; 17: 463-467
46. Johnson SA, Cambier JC Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity. Arthritis Res Ther 2004; 6: 131-139
47. Frasca D, Riley RL, Blomberg BB. Humoral immune response and B cell functions including immunoglobulin class switch are downregulated in aged mice and humans. Semin Immunol 2005; 17: 378-384
48. Haynes L, Eaton SM. The effect of age on the cognate function of CD4+ T cells. Immunol Rev 2005; 205: 220-228
49. Roubenoff R. Physical activity, inflammation, and muscle loss. Nutr Rev 2007; 65: S208-12.
50. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002; 211: 659-666
51. Horiuchi S, Wilmoth JR. Age patterns of the life table aging rate for major causes of death in Japan, 1951-1990. J Gerontol A Biol Sci Med Sci 1997; 52: B67-77.
52. Hainz U, Jenewein B, Asch E, Pfeiffer KP, Berger P, Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 2005; 23: 3232-3235
53. Brydak LB, Machala M, Mysliwska J, Mysliwska A, Trzonkowski P. Immune response to influenza vaccination in an elderly population. J Clin Immunol 2003; 23: 214-222
54. Couch RB, Kasel JA. Immunity to influenza in man. Annu Rev Microbiol 1983; 37: 529-549
55. Kaml M, Weiskirchner I, Keller M et al. Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titres. Vaccine 2006; 24: 6808-6811
56. Keren G, Sergev S, Morag A, Zakay-Rones Z, Barzilai A, Rubinstein E. Failure of influenza vaccination in the aged. J Med Virol 1988; 25: 85-89
57. Gross PA, Quinnan GV Jr, Weksler ME, Gaerlan PF, Denning CR. Immunization of elderly people with high doses of influenza vaccine. J Am Geriatr Soc 1988; 36: 209-212
58. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24: 1159-1169
59. Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-56.
60. Bandeen-Roche K, Xue QL, Ferrucci L et al. Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci 2006; 61: M262-6.
61. Gross PA, Quinnan GV, Weksler ME, Setia U, Douglas RG. Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine 1989; 7: 303-308
62. Fülöp T, Wagner JR, Khalil A, Weber J, Trottier L, Payette H. Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects. J Gerontol A Med Sci Biol Sci 1999; 54: M59-64.
63. Fried LP, Walston J. Frailty and failure to thrive. In Hazzard WR, Blass JP, Ettinger WH Jr, Halter JB, Ouslander J, eds. Principles of Geriatric Medicine and Gerontology. 4th ed. New York: McGraw Hill, 1998: 1387-1402
64. Binder EF, Schechtman KB, Ehsani AA et al. Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial. J Am Geriatr Soc 2002; 50: 1921-1928
65. Walston J, McBurnie MA, Newman A et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002; 162: 2333-2341
66. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 2003; 114: 180-187
67. Leng SX, Xue QL, Tian J, Walston JD, Fried LP. Inflammation and frailty in older women. J Am Geriatr Soc 2007; 55: 864-871
68. Pawelec G. Immunosenescence and vaccination. Immun Ageing 2005; 2: 16.
69. Fülöp T, Larbi A, Hirokawa K et al. Immunosupportive therapies in aging. Clin Interventions Aging 2007; 2: 1-22.
70. Gill TM, Baker DI, Gottschalk M, Peduzzi PN, Allore H, Byers A. A program to prevent functional decline in physically frail, elderly persons who live at home. N Engl J Med 2002; 347: 1068-1074
71. Kohut ML, Cooper MM, Nickolaus MS, Russel DR, Cunnick JE. Exercise and psychosocial factors modulate immunity to influenza vaccine in elderly individuals. J Gerontol A Biol Sci Med Sci 2002; 57: M557-62.
72. Chandra RK. Influence of multinutrient supplement on immune responses and infection-related illness in 50-65 year old individuals. Nutr Res 2002; 22: 5-11.
73. Lesourd B. Nutritional factors and immunological ageing. Proc Nutr Soc 2006; 65: 319-325
74. Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelec G. Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda) 2008; 23: 64-74.
75. Hara M, Tanaka K, Hirota Y. Immune response to influenza vaccine in healthy adults and the elderly: associaton with nutritional status. Vaccine 2005; 23: 1457-1463
76. Kiecolt-Glaser JK, Glaser R, Gravenstein S, Malarkey WB, Sheridan J. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci USA 1996; 93: 3043-3047
77. Iorio AM, Alatri A, Camilloni B, Neri M, Baglio G, Donatelli I. Antibody response to 1995-1996 influenza vaccine in institutionalized and non-institutionalized elderly women. Gerontology 1999; 45: 31-38
78. Hayney MS, Love GD, Buck JM, Ryff CD, Singer B, Muller D. The association between psychosocial factors and vaccine-induced cytokine production. Vaccine 2003; 21: 2428-2432
79. Vedhara K, Bennett PD, Clark S et al. Enhancement of antibody responses to influenza vaccination in the elderly following a cognitive-behavioural stress management intervention. Psychother Psychosom 2003; 72: 245-252
80. Couch RB, Winokur P, Brady R et al. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 2007; 25: 7656-7663
81. Holland D, Booy R, De Looze F et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008; 198: 650-658
82. de Brujin IA, Meyer I, Gerez L, Nauta J, Giezman K, Palache B. Antibody induction by virosomal, MF59-adjuvanted or conventional influenza vaccines in the elderly. Vaccine 2007; 26: 119-127
83. Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyana CM. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001; 75: 12182-12187
84. McElhaney JE, Xie D, Hager WD et al. T cell reponses are better correlates of vaccine protection in the elderly. J Immunol 2006; 176: 6333-6339
85. Trzonkowski P, Mysliwska J, Pawelec G, Mysliwski A. From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly. Biogerontology 2009: 10: 83-94.